Il-17a as potential therapeutic target for patients on peritoneal dialysis

HIGHLIGHTS

• who: Vanessa Marchant et al. from the Díaz-Universidad Autónoma Madrid, Madrid, Spain have published the article: IL-17A as Potential Therapeutic Target for Patients on Peritoneal Dialysis, in the Journal: (JOURNAL)
• what: The authors focus on the effects of these IL-17A-producing cells present in peritoneal + /IL-17A+ ), γδ T lymphocytes, neutrophils, and mast cells . Interestingly, this study compared conventional and low-GDP bicarbonate/lactate-based PDF, showing a large difference in inflammatory response.
• future: IL-17A blockade by neutralizing antibodies has already reached the clinical development stage thus facilitating . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.